星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-20 一张爬行卡来自安徽省

接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿

25 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-19 ms6000000741257643 来自广西

sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish

100 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2022-03-29 Jessy-feng

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：代谢
经验分享：今早收到接收邮件
提交：2022-1-19
under review: 2022-1-22
processing decision: 2022-2-12
decision send back to author: 2022-2-15(小修)
提交：2022-3-20
Initial QC: 2022-3-20
under review:2022-3-24
processing decision:2022-3-25
accept:2022-3-29

64 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-02-14 白衣13 来自香港

Under Review 2023-12-15 14:51
Initial QC 2023-12-14 23:56
Manuscript Submission 2023-12-14 23:08

好慢好慢，求心软审稿人和编辑

48 38

展开38条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-07-05 Z2ThyJ

编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-24 ms7000001747533725 来自四川省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？

24 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-24 145d6ac2m29暂无昵称来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：医学
经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-20 曹白鱼来自江西省

等了三个月返修了结果on hold了，😡😡😡

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-03-23 biocell160 来自贵州省

under review，第9天，求点顺利接收了的大佬们的运气！

36 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210835, encodeId=d9bf221083585, content=接收了，版面费交了，还没发表，突然on hold，纠结撤不撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/08/5b889fbb33c91da6be7e477086dc202f.jpg, createdBy=ccf82499854, createdName=一张爬行卡, createdTime=Thu Jun 20 15:33:10 CST 2024, time=2024-06-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2210721, encodeId=a4552210e21d5, content=sb杂志，tm的on hold了，刚交版面费没多久，文章还没publish, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Wed Jun 19 22:10:18 CST 2024, time=2024-06-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187290, encodeId=d7b9218e290f1, content=Under Review 2023-12-15 14:51 Initial QC 2023-12-14 23:56 Manuscript Submission 2023-12-14 23:08 好慢好慢，求心软审稿人和编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Feb 14 15:57:59 CST 2024, time=2024-02-14, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2213507, encodeId=8911221350e77, content=编辑一直不回消息，撤稿也撤不了，咋回事啊？怎么办啊？编辑不会罢工了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcfc5196066, createdName=Z2ThyJ, createdTime=Fri Jul 05 23:27:02 CST 2024, time=2024-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211334, encodeId=ff912211334b7, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请教：on hold 对已经见刊，有wos号的文章有影响吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6426432168, createdName=ms7000001747533725, createdTime=Mon Jun 24 10:48:36 CST 2024, time=2024-06-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2211488, encodeId=320a2211488f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学 经验分享：这个期刊对普通科研团队来说并不水！我们2023年年底投了这个期刊，做了巨大量的工作，正文7张图，补充材料14张附图，每张图中几乎都是8、9甚至十几个小图，当初选中这个杂志是看到它2022~2023年都不在中科院预警期刊里，感觉应该比frontiers和mdpi系列的杂志靠谱，所以才把用于毕业的文章投在这个杂志上！怎么Scientific report和plos one都不被预警？真就是杂志社背靠大树好乘凉？没有背景的普通科研团队想发表文章真的很不容易！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b75092271, createdName=145d6ac2m29暂无昵称, createdTime=Mon Jun 24 21:04:24 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210893, encodeId=beb522108937e, content=等了三个月返修了结果on hold了，😡😡😡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=ya0l25n5atic3rPzicqPlxog&s=100&t=1579688287, createdBy=e8355277998, createdName=曹白鱼, createdTime=Thu Jun 20 21:05:04 CST 2024, time=2024-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2210773, encodeId=abb72210e73fb, content=偏重的研究方向：医学 经验分享：发了邮件撤稿还没回复现在我可以投别的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Thu Jun 20 11:03:44 CST 2024, time=2024-06-20, status=1, ipAttribution=吉林)]

2024-06-20 还没想好叫啥名来自吉林

偏重的研究方向：医学
经验分享：发了邮件撤稿还没回复现在我可以投别的吗

24 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务